Join DIA's Regulatory Affairs and Clinical Safety and Pharmacovigilance Community for this on-demand webinar. Learn how the IDMP standards and PhPIDs are being implemented today to enhance patient safety and support public health resilience.

The ISO Identification of Medicinal Product (IDMP) establishes a harmonized framework for uniquely identifying and describing medicines. At the heart of this framework is the Pharmaceutical Product Identifier (PhPID), which enables interoperable data exchange across regulatory authorities, manufacturers, and healthcare systems worldwide.

By generating global Pharmaceutical Product Identifiers (PhPIDs) at increasing levels of granularity (from substance-only to substance + strength + dose form attributes), regulators, industry and health care professionals can mine adverse event databases for more precise drug-event combinations. For example, PhPID level 3 (substance + dose form) would isolate all events related to a specific dose form or route, enhancing real-time detection of safety issues.

In parallel, PhPIDs offer significant value in managing and preventing drug shortages. A global repository of PhPIDs linked to national medicinal product databases enables faster identification of equivalent alternatives across jurisdictions. This can save days to weeks in crisis scenarios where rapid substitution or cross-border reliance is needed.